Medalist Funds Like These Large-Cap Stocks
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.
Picking the right stocks can be a daunting challenge for individual investors. After all, unless you're a fund manager or an equity analyst, you probably don't have an abundance of time to research dozens of companies to separate the wheat from the chaff. One place to look for help is Morningstar's Ultimate Stock-Pickers feature, in which we examine the portfolios of funds managed by some of our favorite active managers to identify holdings they have in common.
For this week's Five-Star Investor, we applied a similar approach across all medalist funds in the three domestic large-cap categories. Medalist funds are those that have earned Morningstar Analyst Ratings of Gold, Silver, or Bronze, meaning, among other things, that they offer quality management that uses a well-considered approach. We have excluded index funds which, by their nature, own stocks that are part of an index rather than those hand-picked by a manager. Also, funds available only through financial advisors or those in institutional share classes are included.
A few things to keep in mind: Because funds report their portfolio data on different dates, some information may be more current than others. But in all cases portfolio information represents a snapshot of what the fund held at some date in the recent past and not necessarily what it holds today. Also keep in mind that more than one fund from the same fund company may own a stock. This is to be expected given that fund managers from the same shop often draw from the same research in picking stocks, and in some cases the same manager may be managing multiple funds holding the same stocks. For example, Comcast (CMCSA) is owned by 19 different large-growth medalist funds, including six from Fidelity alone.
Also, our exercise doesn't measure the percentage of the funds' portfolios that each stock represents. For example, one stock may be owned by 10 funds but represent less than 1% of their holdings on average whereas another might be held by only five funds but represent 5% of their holdings on average. The point here isn't the extent to which the funds own a stock but rather the number of funds that have vetted the stock and found it to be a worthwhile holding.
The tables below include some interesting findings regarding the most widely held stocks among medalist funds in the large-blend, large-value, and large-growth categories. Some names on the list come as no great surprise--you'll see ample helpings of blue chips. But surprises do pop up here and there. For example, a look at the large-blend list shows many expected names, such as Apple (AAPL), Google (GOOG), and ExxonMobil (XOM), which are among the largest companies in the S&P 500, but also some smaller names, such as CVS Caremark (CVS), Texas Instruments (TXN), and Time Warner , which rank much further down in the index. The large-growth list also includes some surprises, including Monsanto , Salesforce.com (CRM), and LinkedIn , which fall outside the list of top holdings for the Russell 1000 Growth Index.
Meanwhile, the only stock appearing on all three lists is Microsoft (MSFT), which serves as a reminder that funds with a growth, blend, or value bent don't necessarily stick with just one type of stock. For example, a fund with a value tilt might own Microsoft as a way to add tech-sector exposure to its portfolio even though the stock isn't selling at a deep discount.
The fact that a particular stock is widely owned by quality funds in a specific category doesn't necessarily mean it's a good buy or the right stock for you. You should pay attention to the Morningstar Rating for a given stock, which indicates how a company's current share price relates to our analyst's fair value estimate. You should also look at our fair value uncertainty rating for the stock, which indicates our analyst's level of conviction in that fair value estimate. However, finding that a stock is on at least one of these lists may offer you some level of assurance that it's considered a good holding by several quality fund managers, at least for now.
Most Widely Held Stocks Among Large-Growth Medalist Funds | ||||
Company | # Funds Owning | Russell Index Ranking * | Industry | Star Rating |
Google (GOOG) | 54 | 2 | Internet Content & Info | |
Visa (V) | 39 | 15 | Credit Services | |
Amazon.com (AMZN) | 38 | 7 | Specialty Retail | |
Apple (AAPL) | 36 | 1 | Consumer Electronics | |
Biogen Idec (BIIB) | 35 | 28 | Biotech | |
Facebook (FB) | 35 | 17 | Internet Content & Info | |
MasterCard (MA) | 34 | 21 | Credit Services | |
Monstanto | 34 | 36 | Agricultural Inputs | |
Gilead Sciences (GILD) | 31 | 13 | Biotech | |
Schlumberger (SLB) | 27 | 14 | Oil & Gas Eq. Svs | |
Salesforce.com (CRM) | 26 | 60 | Software-Application | |
Starbucks (SBUX) | 26 | 39 | Restaurants | |
Priceline.com (PCLN) | 25 | 35 | Leisure | |
Nike (NKE) | 24 | 42 | Footwear & Accessories | |
Qualcomm (QCOM) | 24 | 11 | Communication Eq. | |
21st Century Fox | 24 | 45 | Media-Diversified | |
Union Pacific (UNP) | 23 | 23 | Railroads | |
22 | 94 | Internet Content & Info | ||
Alexion Pharmaceuticals | 21 | 71 | Biotech | |
Amgen (AMGN) | 21 | 22 | Biotech | |
Costco (COST) | 21 | 44 | Discount Stores | |
Microsoft (MSFT) | 21 | 3 | Software-Infrastructure | |
Precision Castparts | 21 | 54 | Metal Fabrication | |
Walt Disney (DIS) | 21 | 75 | Media-Diversified | |
Total number of funds: 59 (active management only) Star Ratings as of Feb. 7 * Rank in Russell 1000 Growth Index |
Most Widely Held Stocks Among Large-Blend Medalist Funds | ||||
Company | # Funds Owning | S&P 500 Ranking | Industry | Star Rating |
Microsoft (MSFT) | 34 | 4 | Software-Infrastructure | |
Wells Fargo (WFC) | 28 | 7 | Banks-Global | |
Google (GOOG) | 24 | 3 | Internet Content & Info | |
Cisco Systems (CSCO) | 21 | 27 | Communication Eq. | |
Johnson & Johnson (JNJ) | 21 | 6 | Drug Mfr.-Major | |
Apple (AAPL) | 20 | 1 | Consumer Electronics | |
ExxonMobil (XOM) | 20 | 2 | Oil & Gas Eq. | |
JPMorgan Chase (JPM) | 20 | 9 | Banks-Global | |
PepsiCo (PEP) | 20 | 26 | Beverages-Soft Drinks | |
Procter & Gamble (PG) | 20 | 10 | Household/Personal Prod. | |
UnitedHealth Group (UNH) | 20 | 52 | Health-Care Plans | |
CVS Caremark (CVS) | 17 | 45 | Pharmaceutical Retailers | |
Chevron (CVX) | 17 | 8 | Oil & Gas Integrated | |
Texas Instruments (TXN) | 17 | 85 | Semiconductors | |
Coca-Cola (KO) | 16 | 18 | Beverages-Soft Drinks | |
Qualcomm (QCOM) | 16 | 24 | Communication Eq. | |
Merck (MRK) | 15 | 16 | Drug Mfr.--Major | |
Occidental Petroleum (OXY) | 15 | 50 | Oil & Gas E&P | |
Philip Morris (PM) | 15 | 23 | Tobacco | |
Time Warner | 15 | 65 | Media-Diversified | |
Total number of funds: 44 (active management only) Star Ratings as of Feb. 7 |
Most Widely Held Stocks Among Large-Value Medalist Funds | ||||
Company | # Funds Owning | Russell Index Ranking * | Industry | Star Rating |
Pfizer (PFE) | 27 | 8 | Drug Mfr.-Major | |
Microsoft (MSFT) | 26 | N/A | Software-Infrastructure | |
JPMorgan Chase (JPM) | 25 | 6 | Banks-Global | |
Chevron (CVX) | 24 | 5 | Oil & Gas Integrated | |
Merck (MRK) | 23 | 12 | Drug Mfr.-Major | |
Johnson & Jonson (JNJ) | 22 | 3 | Drug Mfr.-Major | |
Wells Fargo (WFC) | 22 | 4 | Banks-Global | |
General Electric (GE) | 20 | 2 | Diversified Industrials | |
PNC Financial Serv. (PNC) | 20 | 36 | Banks-Regional/U.S. | |
Citigroup (C) | 19 | 13 | Banks-Global | |
AT&T (T) | 18 | 11 | Telecom Services | |
Cisco Systems (CSCO) | 18 | 14 | Communication Eq. | |
ExxonMobil (XOM) | 17 | 1 | Oil & Gas Integrated | |
Procter & Gamble (PG) | 15 | 7 | Household/Personal Prod. | |
Time Warner | 14 | 25 | Media-Diversified | |
UnitedHealth Group (UNH) | 14 | 22 | Health-Care Plans | |
Bank of America (BAC) | 13 | 10 | Banks-Global | |
MetLife (MET) | 13 | 35 | Insurance-Life | |
Occidental Petroleum (OXY) | 13 | 21 | Oil & Gas E&P | |
Verizon (VZ) | 13 | N/A | Telecom Services | |
Total number of funds: 36 (active management only) Star Ratings as of Feb. 7 * Rank in Russell 1000 Value Index |
Now that you've seen these lists, you might try building your own. If you don't already have a list of funds whose holdings you'd like to examine, use the Premium Fund Screener tool or the Morningstar Medalists fund screener tool to come up with your own list. Then build your own portfolio using the Portfolio Manager or Instant X-Ray tool (you can read more about how to do this here). Last, X-ray the portfolio and choose the (Stock) Intersection tab to see the portfolio's underlying holdings and which funds own which stocks. You might find some surprises of your own. You can also click on the Ownership tab on any stock page to learn more about which funds own it.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.